Display options
Share it on

Chin Med. 2011 Jan 24;6:4. doi: 10.1186/1749-8546-6-4.

Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells.

Chinese medicine

Ding-Fung Toh, Dhavalkumar Narendrabhai Patel, Eric Chun-Yong Chan, Alvin Teo, Soek-Ying Neo, Hwee-Ling Koh

Affiliations

  1. Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543, Singapore. [email protected].

PMID: 21255464 PMCID: PMC3037355 DOI: 10.1186/1749-8546-6-4

Abstract

BACKGROUND: Panax notoginseng is a potential source of anticancer compounds. This study aims to investigate the effects of steaming on the chemical profile of P. notoginseng and the anti-proliferative effects of P. notoginseng on liver cancer cells.

METHODS: Samples of powdered raw P. notoginseng roots were steamed for various durations. Extracts of the raw and steamed samples were subjected to ultra-high pressure liquid chromatography/mass spectrometry (UHPLC-MS) analysis for chemical profiling. The anti-proliferative effects on three human liver cancer cells, namely SNU449, SNU182 and HepG2, were evaluated using colorimetric WST-1 assay.

RESULTS: Steaming changed chromatographic and pharmacological profiles of P. notoginseng, causing differences in activities such as inhibition of cancer growth. Steamed P. notoginseng exhibited greater anti-proliferative effects against liver cancer cells (SNU449, SNU182 and HepG2) than its raw form; steaming up to 24 hours increased bioactivities. Steaming increased the concentrations of ginsenoside Rh2, Rk1, Rk3 and 20S-Rg3 and enhanced growth inhibition of liver cancer cells.

CONCLUSION: Steaming changes the chemical profile as well as anti-cancer biological activities of P. notoginseng. Steamed P. notoginseng contains potential compounds for the treatment of liver cancer.

References

  1. Biol Pharm Bull. 2008 May;31(5):826-30 - PubMed
  2. J Chromatogr A. 2004 Nov 19;1057(1-2):141-9 - PubMed
  3. Adv Food Nutr Res. 2009;55:1-99 - PubMed
  4. J Pharm Biomed Anal. 2010 May 1;52(1):43-50 - PubMed
  5. Rapid Commun Mass Spectrom. 2007;21(4):519-28 - PubMed
  6. Br J Cancer. 2008 Feb 26;98(4):792-802 - PubMed
  7. Int J Oncol. 2009 Jul;35(1):121-7 - PubMed
  8. Int J Oncol. 2007 Nov;31(5):1149-56 - PubMed
  9. Chem Biodivers. 2006 Feb;3(2):187-97 - PubMed
  10. Chin Med. 2007 May 15;2:6 - PubMed
  11. Comb Chem High Throughput Screen. 2008 Jan;11(1):7-15 - PubMed
  12. J Ethnopharmacol. 2009 Sep 25;125(3):380-6 - PubMed
  13. Zhong Xi Yi Jie He Xue Bao. 2006 Sep;4(5):500-3 - PubMed
  14. Zhong Xi Yi Jie He Xue Bao. 2004 Nov;2(6):445-9 - PubMed
  15. J Pharm Pharmacol. 2006 Aug;58(8):1007-19 - PubMed
  16. Biol Pharm Bull. 1999 Oct;22(10):1150-2 - PubMed
  17. J Chromatogr A. 2003 Sep 5;1011(1-2):77-87 - PubMed
  18. Zhong Xi Yi Jie He Xue Bao. 2005 Mar;3(2):123-7 - PubMed
  19. Chem Pharm Bull (Tokyo). 2002 Apr;50(4):538-40 - PubMed
  20. Med Chem. 2007 Jan;3(1):51-60 - PubMed
  21. Mol Cancer Ther. 2008 Jan;7(1):152-61 - PubMed
  22. Cancer Lett. 1996 Dec 20;110(1-2):193-200 - PubMed

Publication Types